In most developed countries, suicide ranks among the leading causes of death for individuals of all ages and it is the leading or the second most common cause of death for young people (see Further information). Owing to the availability of effective treatments for suicidality and associated psychiatric disorders, death by suicide is often avoidable 1 . However, suicide remains, to a large degree, charged with prejudice and stigma, characteristics that do not encourage individuals who experience suicidal ideation or who show suicidal behaviour to reach out and seek help. Despite the extent of its public health effects, there is generally little awareness in society about suicide's toll, which has caused suicide to be referred to as "the quiet epidemic" (REF. 2).
1
. However, suicide remains, to a large degree, charged with prejudice and stigma, characteristics that do not encourage individuals who experience suicidal ideation or who show suicidal behaviour to reach out and seek help. Despite the extent of its public health effects, there is generally little awareness in society about suicide's toll, which has caused suicide to be referred to as "the quiet epidemic" (REF.
2).
Suicide completion is commonly regarded as the extreme end of a continuum that also includes suicide attempts and suicidal ideation 3 . For the purpose of this Review, suicidality will be used to refer to both suicidal ideation and suicidal behaviours, and suicidal behaviours will be considered as a single entity. However, there is a debate about the relationship between these phenotypes and disagreement about the inclusion of other presentations of self-harm, such as non-suicidal selfinjurious behaviours, in this continuum 4 . There is considerable variability among and within suicidality categories in terms of the level of intent to self-harm, the severity of the self-harm outcome and the associated psychopathology, among other features. Indeed, most individuals presenting with suicidal behaviour are affected by a psychiatric disorder 5, 6 , an association which is strongest among suicide completers; approximately 90% of individuals who die by suicide are affected by a psychiatric disorder before death, mainly by major depressive disorder (MDD), schizophrenia, substance-related disorders and/or personality disorders 6 . Of note, suicidal behaviour disorder was recently proposed as a diagnosis for consideration for the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 7 . The variability among and within suicidality categories probably reflects the underlying aetiological hetero geneity of suicidality and its related psychopathology. Other variables could also be used to partly explain the observed variability in each phenotypic suicidality group. Among suicide completers, differences in psycho pathology, personality traits and suicide intent between individuals may be age related; for example, impulsive aggressive traits are more strongly linked to suicide in young subjects 8, 9 . In addition, sex contributes to phenotypic variability in each category; male and female suicide attempters and suicide completers show clear differences in the methods used, their underlying psychopathology and comorbid diagnoses 10, 11 . Thus, models of suicidal behaviours, including biological factors predisposing individuals to and mediating these phenotypes, will probably explain only a proportion of the total phenotypic variability that is observed. Nevertheless, they are helpful as they provide important conceptual frameworks that enhance our understanding of suicide-spectrum behaviours and can guide us towards new hypotheses.
There are many models of suicide risk 12 and most are conceptually related to the initial model that was proposed by Moscicki 13 and its refined version that was presented
Suicidality
This broad term encompasses all forms of suicidal behaviour and suicidal ideation.
Suicidal ideation
This term describes the wish to die, including thoughts of actively ending one's life.
Suicidal behaviour
This term describes behaviours that result in self-injury and is generally used to refer to suicide attempts and suicide completion.
Self-harm
This broad term includes suicidal behaviour and non-suicidal self-injurious behaviours.
Non-suicidal self-injurious behaviours
Deliberate self-injury, often in the form of superficial skin cuts that are made with the intent to decrease emotional pain rather than to die.
Suicidal behaviour disorder
This disorder has recently been proposed as a condition for further study in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and is defined by the occurrence of at least one suicide attempt with some intent to die within the last 24 months. Conditions for further study in the DSM are disorders that should be investigated and considered for its future versions.
Suicidal crisis
Period when suicidal ideation becomes acute, which is often associated with emotional instability.
Distal risk factors
Predisposing factors that occur or are expressed temporally distant from the onset of the phenotype.
Early-life adversity (ELA) . Acts by a parent or caregiver that result in physical, sexual and/or psychological abuse of a child or that lead to neglect of essential physical or psychological needs of childhood.
Treatment-emergent suicidal events
This term describes suicidal ideation or suicidal behaviour that occurs in association with treatment and is a common term used in clinical trials of antidepressants.
Childhood sexual abuse
Any completed or attempted sexual act, or exposure to sexual interactions, with or without physical contact, with a child by a caregiver.
Childhood physical abuse
The intentional use of physical force against a child that results in, or has the potential to result in, physical injury.
Parental neglect
Failure to meet a child's basic physical, emotional, medical or dental, or educational needs, or a failure to ensure a child's safety.
by Mann 14 . These models are based on the premise that suicide results from the interaction of risk factors acting distally to the suicidal event, which increase predisposition to such an event, with those acting proximally to the suicidal event, which precipitate the suicidal crisis. In this Review, I describe the relationships between such distal and proximal factors, focusing on molecular events that predispose individuals to suicidality, that mediate suicidal ideation and behaviour, and that precipitate suicidal crises, rather than on the neural circuitry of suicidal behaviour.
Distal or predisposing factors
Distal factors confer risk of suicide but have a distant temporal relationship to the suicidal crisis. As such, these factors increase predisposition to suicide rather than precipitate suicidal crises. Among distal risk factors for suicide, family history, genetic variation and early-life adversity (ELA) are the best investigated.
Familial and genetic predisposition. Many studies examining family history of suicidal behaviour, including a recent large registry study that comprised the total population of Sweden 15 , as well as studies directly interviewing relatives of probands with suicidal behaviour, have shown that suicidal behaviour runs in families, with relatives of suicide probands who have died by suicide estimated to have a 3-10-fold greater risk of suicidal behaviour than relatives of control individuals [15] [16] [17] . As suicidal behaviour is strongly associated with psychopathology (see below) and psychiatric disorders also run in families, considerable effort has been made to understand to what extent the liability to suicidal behaviour is different from the liability to psychiatric disorders. In contrast to suicidal behaviour, suicidal ideation does not seem to be as clearly linked to a family history of suicidal ideation [18] [19] [20] , although a family history of suicide attempt or completion does predict a higher frequency of suicidal ideation (2.41-5.1-fold greater risk) 20, 21 . Studies have shown that familial transmission of suicide and psychopathology, although partly overlapping, are distinct 19, 22, 23 . Thus, familial aggregation of suicide cannot be explained by the transmission of psychopathology 23 .
Evidence that the familial aggregation of suicidal behaviour is at least partly due to genetic factors has been provided by several twin studies, which have yielded variable estimates of heritability but have consistently indicated an increased concordance of such behaviour in monozygotic twins compared with dizygotic twins 15, 16 . Adoption studies have shown concordant results, finding that biological relatives of adoptees who had committed suicide have a higher rate of suicide than relatives of adoptees who had died by other causes 15, 24 , and that parental suicide confers a similar level of suicide risk on adopted-away and non-adopted offspring 25 .
Genetic variation.
Guided by the genetic epidemiological data suggesting that genes increase predisposition to suicidal behaviour, many molecular genetic studies have been carried out over the past two decades to identify the genetic variants that may be used to explain liability to suicide. As for other psychiatric phenotypes, most studies used a candidate gene association approach and have particularly focused on genes coding for components of the serotonergic system, given the evidence suggesting that suicidal behaviour is associated with decreased serotonergic neurotransmission 26, 27 . In particular, the genes coding for the serotonin transporter tryptophan hydroxylase and monoamine oxidase A have been widely studied in molecular analyses owing to their well-defined roles in serotonin metabolism 26, 28 . Unfortunately, given the lack of consistent findings between studies, the evidence from candidate gene-based association studies told us little about the contributions of specific genes.
Genome-wide association studies (GWASs) of suicidal behaviour or of treatment-emergent suicidal events have more recently been carried out to identify novel loci (see Supplementary information S1 (table)) [29] [30] [31] [32] [33] [34] . Although these have mostly produced inconclusive or inconsistent results, it is notable that such approaches facilitate an un biased analysis of molecular pathways that are implicated in disease and are an important method to use. For example, a GWAS identified 14 single-nucleotide polymorphisms (SNPs) that were associated with treatmentemergent suicidal ideation in patients who had been treated with antidepressants 30 , and another study examining suicide completers identified seven genes that were differentially expressed in suicide completers compared with control individuals but not in individuals with mood disorders 35 . However, most of the GWASs used fairly small samples that lacked the power to detect effects other than major gene effects and their results require confirmation. In many of the large-scale GWASs that have been carried out to date, SNPs that have been identified to be of interest in the discovery phase of studies have not been identified as such in replication cohorts [31] [32] [33] [34] 36 .
Early-life adversity. Several lines of evidence support a strong relationship between ELA -such as experiences of childhood sexual abuse, childhood physical abuse and parental neglect -and lifetime risk of suicidal behaviour. This evidence comes from prospective cohort studies that have investigated epidemiologically representative samples 5, 37 , and retrospective cross-sectional studies that have investigated epidemiological and clinical samples 38, 39 . Maltreatment during early development is also among the strongest predictors of psychiatric pathology and of a severe clinical course for psychiatric disorders, including early onset of illness, poor treatment response and increased comorbidity [40] [41] [42] . However, the specific association between ELA and lifetime risk of suicidal behaviour is robust and cannot solely be explained by the link between psychiatric disorders and childhood maltreatment 43, 44 . Between 10% and 73% of individuals who manifest suicidal behaviour have a history of childhood abuse (the rate depends on the type and frequency of the abuse, and the form of suicidal behaviour) 37, [45] [46] [47] . Thus, this association can only be used to explain a proportion, albeit a notable to substantial one, of the total variance in risk of suicidality. A few important factors determine the strength of the relationship between childhood abuse and
Attachment styles
Stereotypical interpersonal styles that are rooted in early-life interactions with caregivers.
Biological embedding
The effects of early-life experiences on the differential regulation of biological systems and development.
Mediators
Variables that can fully or partially explain the relationship between a predictor and a dependent variable.
suicidal behaviour, including the sex of the abused, the identity of the abuser and the frequency of the abuse. For example, the risk of suicidal behaviour is higher among individuals who have experienced abuse by close caregivers than among individuals who have experienced abuse by extended family members or unrelated individuals, and frequent abuse increases the risk of suicidal behaviour 44 . During development, immediate caregivers are responsible for the establishment of adequate attachment styles and appropriate emotional responses to environmental and stress-related stimuli throughout the life of the individual 48, 49 . Attachment styles define the ways in which individuals relate to others and can be broadly divided into secure and insecure attachments, with insecure attachments being characterized by anxiety or avoidance 50 . Thus, frequent exposure to maltreatment by those who are supposed to provide protection and care may signal that the environment is hostile. These signals in turn may prompt the developing brain to adjust stress-response circuits to adapt to this hostile environment by increasing levels of alertness. In support of this hypothesis, studies suggest a relationship between poor parent-child attachment, maladjustment in the parental role and childhood abuse, and suicidal behaviour 37, 50 .
Biological systems affected by early-life adversity.
Biological embedding refers to the effects of early-life experiences on the differential regulation of biological systems and development 51 . Important insight into systems and pathways that undergo biological embedding and the underlying molecular mechanisms responsible for this has come from animal studies that clearly suggest that variation in the early-life environment associates with stable expression changes in genes that are important for key behavioural and stress responses.
Indeed, animal studies have shown that epigenetic processes, particularly DNA methylation of various genes in different brain structures, mediate biological embedding
.
Findings from animal studies have led to a growing interest in the investigation of epigenetic factors -primarily DNA methylation -as possible mediators of biological embedding resulting from ELA in humans. Although theoretically appealing, studying methylation changes caused by ELA in humans and associating them with behavioural and emotional phenotypes poses several operational and logistical challenges. Epigenetic changes are tissue and cell-type specific but sampling brain tissue from living subjects is impossible. Thus, epigenetic studies on human brains are limited to post-mortem specimens. Although post-mortem studies are informative, it is difficult to establish temporal relationships between epigenetic marks and behavioural phenotypes from such studies. By contrast, peripheral samples are less challenging to obtain but the extent to which they are informative about processes occurring in the CNS is under debate. In spite of these challenges, several epigenetic studies have been carried out investigating CNS and peripheral samples from individuals who have been exposed to ELA.
Of particular interest in the context of suicidal behaviour is the regulation of the hypothalamus-pituitaryadrenal (HPA) axis. The activation of the HPA axis leads to cortisol release, which is a steroid hormone secreted in response to stress that promotes arousal and attention, among other physiological changes 52 . Cortisol also binds to the glucocorticoid receptor in the hippocampus to inhibit further stimulation of the HPA axis in a negative feedback loop. The HPA axis is overactive in individuals exposed to ELA, who are more likely than control individuals to show heightened stress responsiveness 53 . As such, nuclear receptor subfamily 3 group C member 1 (NR3C1), which encodes the glucocorticoid receptor, has been widely studied. Several animal studies have suggested that the early environment regulates Nr3c1 through DNA methylation changes
. The first evidence for an effect of ELA on the human epigenome indicated that childhood abuse or severe neglect in humans regulates both the patterns and the levels of NR3C1 methylation in the hippocampus, which can lead to increased HPA axis reactivity in humans who have been exposed to childhood maltreatment 54 . Individuals who died by suicide and had histories of severe childhood abuse had a marked decrease in the levels of both total NR3C1 mRNA and untranslated exon 1 F variant NR3C1 mRNA compared with individuals who died by suicide and did not have a history of childhood abuse and non-suicide controls. This decreased mRNA expression was associated with increased methylation in the exon 1 F promoter, particularly in a region where the transcription factor nerve growth factor-induced protein A (NGFIA; also known as EGR1) binds, a finding that is in line with evidence from rats
. Studies carried out in vitro suggested that this increased methylation that was observed in suicide completers with histories of abuse could interfere with NGFIA binding of the NR3C1 promoter, resulting in decreased glucocorticoid receptor expression 54 .
Box 1 | Biological embedding through DNA methylation
Biological embedding refers to the effects of early-life experience on the regulation of biological systems 51 . Animal studies have provided important insight into the mechanisms that can be used to explain biological embedding. One of the best-investigated models is the maternal care model in rats, which makes use of naturally occurring variations in quantifiable behaviours (for example, licking and grooming, and arched-back nursing) in nursing rat mothers. Variations in maternal care have marked and stable effects on endocrine and behavioural responses in the offspring; for example, increased tactile stimulation by mothers dampens the hormonal response to stress 202 and reduces behavioural fearfulness 103 . Other animal models, such as induced maternal abusive behaviours in rats 74 or early-life stress in mice 203 , have shown similar effects. Subsequent studies in animals have shown that epigenetic processes, particularly DNA methylation involving different genes and brain structures, mediate biological embedding 204 . DNA methylation refers to the addition of a methyl group (CH 3 ) to the 5ʹ carbon of a cytosine base. DNA methylation occurs commonly, but not exclusively, at sequences composed of cytosines followed by guanines (known as CpG dinucleotides). Cytosine methylation is generally associated with transcriptional repression, which occurs by interference with the recruitment and binding of transcriptional machinery to gene regulatory regions 205 . However, in studies identifying DNA methylation within the gene body, it has been associated with transcriptional activation and alternative transcript selection 206 . DNA methylation is theoretically dynamic, but this is only the case for a minority of CpGs 207 and thus DNA methylation is generally a stable process that is involved in long-term gene silencing, including X chromosome inactivation, suppression of alternative promoters and tissue-specific suppression of gene regulation.
Since the initial study linking glucocorticoid receptor methylation in the brain with childhood abuse was published 54 , several independent studies have been carried out to investigate the relationship between NR3C1 exon 1 methylation, ELA and suicidal behaviour or psychopathology, including phenotypes that are associated with altered parental care [55] [56] [57] [58] [59] [60] (see Supplementary  information S2 (table) ). Although these studies were carried out using different study designs, measures of adversity and tissue samples, there is a remarkable consistency Box 2 | Effect of early-life adversity on the hypothalamus-pituitary-adrenal axis
The hypothalamus-pituitary-adrenal (HPA) axis is activated by stress (see the figure) . Following activation, the hypothalamus secretes corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP), which act on the anterior pituitary gland to trigger the release of adrenocorticotropic hormone (ACTH). This stimulates the adrenal cortex to produce cortisol, which heightens alertness. Cortisol-mediated activation of glucocorticoid receptors in the hippocampus exerts negative feedback on activity of the HPA axis. The glucocorticoid receptor-encoding gene, nuclear receptor subfamily 3 group C member 1 (NR3C1), is downregulated in the hippocampus of individuals who have been exposed to early-life adversity (ELA), which leads to ineffective inhibition of CRH secretion and an overactive HPA axis. This overactive HPA axis may be associated with the development of anxiety traits, which in turn are mediators of suicidal behaviour risk.
In humans, NR3C1 mRNA may contain one of 11 untranslated splice variants of exon 1, which are encoded by seven different variants of exon 1, each with its own promoter, and each mRNA variant has a unique tissue-specific distribution 208 . There is remarkable homology between the structure of exon 1 in humans and rats 208, 209 , and mRNAs containing exon 1 7 (in rats) and 1 F (in humans) are highly expressed in the hippocampus 208 . CpG methylation levels in the exon 1 7 promoter region are markedly increased at almost all CpGs in offspring raised by low licking and grooming rat mothers, whose increased physical attention to pups results in attenuated stress responses (BOX 1) compared with offspring raised by high licking and grooming mothers. Importantly, one CpG nucleotide located in the 5ʹ end of the binding site of the transcription factor nerve growth factor-induced protein A (NGFIA) is methylated in almost all offspring raised by low licking and grooming mothers, whereas it is almost never methylated in offspring from high licking and grooming mothers 204 .
Other animal studies investigating the effects of early-life environments on behavioural phenotypes have shown comparable results in genes encoding components of the HPA axis or other key gene systems. For example, in mice, maternal deprivation (that is, placement in a cleaned cage devoid of maternal odour for 3 hours per day for the first 10 days of life) produces sustained hyperactivity of the HPA axis that is characterized by increases in stress-induced corticosteroid secretion and in the expression of pro-opiomelanocortin (POMC) in the pituitary gland, and hypertrophy of the adrenal glands 203 . These changes in POMC expression are associated with sustained Pomc promoter hypomethylation 210 . These mice also present increased despair-like behaviour and memory deficits, phenotypes that are mediated through AVP signalling and epigenetic adaptations at an AVP enhancer locus. Accordingly, mice subject to early-life stress present a persistent increase in AVP expression in the hypothalamic paraventricular nucleus (PVN), which associates with decreased DNA methylation of an Avp enhancer element located in the intergenic region between Avp and the gene encoding oxytocin, where methyl-CpG-binding protein 2 (MECP2) binds. As a result, MECP2 occupancy of this Avp regulatory sequence is decreased, leading to sustained increased AVP expression 203 . Such overexpression of AVP can result in HPA axis hyperactivity and altered coping mechanisms that resemble depression in humans. In adult animals, decreased AVP promoter methylation in the amygdala is associated with active coping mechanisms after exposure to stressful stimuli 211 , and AVP expression is associated with aggressive behaviour [212] [213] [214] . Collectively, animal studies on early-life environmental variation 74, 204 indicate that the early environment epigenetically regulates diverse genomic loci that are important in the regulation of emotional and behavioural traits of relevance to depression and suicide. in their findings, which mainly show increased levels of methylation in NR3C1 exon 1 F among individuals exposed to less favourable environmental experiences during early life. Epigenetic processes are essential in the differentiation of cells and tissues, as well as in the developmental regulation of genes. Thus, there is a predictably higher variability when comparing epigenetic patterns between tissues from the same individual than when comparing the same tissue from different individuals 61 . However, there is also evidence of within-individual epigenetic variant correlation across tissues 61 . The consistency in the NR3C1 methylation findings observed using different tissues suggests that social adversity may activate systemic signals, such as steroids or other hormones, that may affect epigenetic patterns in multiple tissues.
A different line of evidence suggesting that ELA regulates the activity of the HPA axis through differential methylation comes from studies investigating FK506-binding protein 5 (FKBP5). This protein regulates the glucocorticoid receptor by decreasing its capacity to bind glucocorticoids, which hampers the ensuing translocation of the glucocorticoid receptor complex to the nucleus. Certain sequence variants of FKBP5 put individuals at increased risk of depression and post-traumatic stress disorder 62, 63 , and of showing suicidal behaviour [64] [65] [66] or experiencing suicidal events in the course of antidepressant treatment 67, 68 ; the link with suicidality is particularly strong for subjects with a history of ELA 69, 70 . Interestingly, one study reported that the interaction between the FKBP5 genotype and ELA occurs through decreased methylation affecting functional glucocorticoid response elements located in intron 7 of FKBP5, which results in a downstream increase in FKBP5 expression and glucocorticoid receptor resistance 71 .
ELA also differentially regulates genes and pathways involved in neuronal plasticity. For example, genomewide methylation studies in hippocampal tissue from individuals who died by suicide and had histories of ELA indicated that ELA was associated with differential methylation of genes involved in neuronal growth and neuroprotection 57, 72 . Studies in peripheral samples from living subjects also suggested that a history of ELA was linked to differential methylation of neuronal plasticity genes 73 . These findings are concordant with animal studies that support early-life environmental regulation of plasticity genes, such as the gene coding brain-derived neurotrophic factor (BDNF). Experiments carried out in rodents showed that when gestating females were put under conditions of stress (in this case, introduction to a new environment with inadequate bedding material), the expression of Bdnf was dysregulated. Specifically, Bdnf mRNA expression was decreased in the prefrontal cortex, and this decreased expression correlated with hypermethylation of the Bdnf promoters in exons 4 and 9 (REF. 74 ). Similar effects have been reported for the Bdnf exon 4 promoter in the dorsal hippocampus in an adult rat model of post-traumatic stress disorder 75 . Another neurotrophic factor, glial cell line-derived neurotrophic factor (GDNF), is also epigenetically regulated by environmental experience in rodents through chromatin modification and DNA methylation of its gene promoter, and these changes are associated with behavioural responses to chronic stress 76 . However, these methylation changes in Gdnf were observed in adult mice, which thus suggests that the epigenetic programming of neurotrophic factors such as GDNF may not be limited to developmental periods. It remains unclear whether the epigenetic changes that occur as a result of ELA are of a similar quality, intensity and stability if they occur during childhood or later in life
Box 3 | Stability of DNA methylation changes over time
In well-characterized brain circuits, brain plasticity is considerably more pronounced during childhood than in later years 215 , and clinical studies suggest that abusive experiences during early-life are more likely to result in pervasive behavioural phenotypes than similar events experienced in adulthood [216] [217] [218] . However, the relationship between timing of the stressor, epigenetic effect and behavioural consequences remains one of the most crucial questions in epigenetic studies of mental health phenotypes.
Recent publications have begun to explore longitudinal analyses of methylation in relation to the subject's environment. Although the stability of epigenetic changes over time has not yet been clearly shown, a study evaluating methylation at a wide range of loci indicates that DNA methylation is likely to be stable over long periods of time (11-20 years) 219 . Although this finding requires confirmation, it is interesting to note that the authors specifically examined genes involved in the stress response -nuclear receptor subfamily 3 group C member 1 (NR3C1) and corticotropin-releasing hormone (CRH) -and found their methylation status to be stable over time. In addition, emotional adversity during childhood effects long-term changes in methylation. In a study evaluating monozygotic twins at 5 and 10 years of age, Ouellet-Morin and colleagues 220 showed that children who had experienced bullying had increased methylation at the serotonin transporter (SERT) compared with their non-bullied monozygotic twin 220 . Interestingly, this study also showed that individuals with increased SERT methylation showed a decreased cortisol response to stressful situations, which suggests a link between the serotonergic response and the hypothalamus-pituitary-adrenal axis. Lasting changes in DNA methylation also seem to occur into adulthood, as shown by recent studies on post-stroke depression. In patients who had suffered a stroke, those experiencing post-stroke depression or worsening depression during the year following their stroke had increased methylation of the genes encoding brain-derived neurotrophic factor (BDNF) and solute carrier family 1 member 2 (SLC6A4) 221, 222 . Such examples of long-lasting epigenetic changes help us to understand how distal events, such as early-life adversity, can contribute to increased suicide risk, and how proximal events, such as stressful life events, can precipitate suicidal acts by altering gene expression profiles in the brain that have a marked effect on behaviour.
Endophenotypes
Traits that associate with an illness in the population, are heritable, state independent, and co-segregate with the condition investigated and are present in non-affected family members of affected individuals at a higher rate than in the general population.
Impulsive aggressive behaviours
The tendency to react with animosity or overt hostility without consideration of the possible consequences when piqued or under stress.
BDNF and the gene that encodes its high-affinity receptor, tropomyosin-related kinase B (TRKB), have received considerable attention in human studies of suicidal behaviour, although most of these studies have not examined whether the participants had a history of ELA. Some of these studies have revealed that suicide completers have decreased mRNA and/or protein levels of BDNF, TRKB or both in the prefrontal cortex [77] [78] [79] [80] , temporal cortex 81 and hippocampus 77, 82 . Moreover, others have reported differential methylation patterns in regulatory regions of BDNF and TRKB 79, 82 . Specifically, in the Wernicke area of suicide completers, four CpG sites located downstream of transcription initiation site of the promoter in exon 4 of BDNF were more highly methylated in suicide completers than in control individuals, and this increased methylation was associated with markedly lowered BDNF expression, which is consistent with the expected repressive effects of methylation in promoter sequences on transcription 83 . In line with these findings, recent studies have reported that living patients with depression show differential methy lation of the BDNF promoter in peripheral samples [84] [85] [86] . In addition, studies have revealed that suicide completers have differential methylation in the promoter 79 and in a transcript-specific 3´ untranslated region (UTR) 80 of TRKB in the prefrontal cortex.
In addition to hypothesis-driven studies, a growing number of genome-wide studies have investigated changes in the methylome that are associated with ELA and/or suicide. In spite of the inherent sources of variation when measuring methylation levels 87 and the relatively small sample sizes of these studies, particularly in comparison to those of GWASs, it is noteworthy that epigenome-wide association studies have identified methylation differences at several genomic loci. Studies using peripheral samples 73, 88 and brain samples 57, 72 have shown differential methylation in gene pathways involved in stress, neural plasticity and cognitive processes. Studies that investigated brain tissue and that carried out cell sorting 57, 72 found that these differences were mostly accounted for by methy lation changes in neuronal DNA. These strong associations between ELA and DNA methylation show long-lasting changes in the regulation of gene expression that are triggered by early environment experiences and these changes are strongly linked to suicidal behaviour 89, 90 .
Mediators of suicide risk
Distal factors affect biological systems and, in turn, the resulting changes in these systems can increase the risk of suicide. Thus, distal factors do not directly cause suicidal behaviour. Indeed, if they did, these factors would have been subject to selective pressures and progressively eliminated. Moreover, if distal factors had a direct link with suicide risk, ELA would have a more specific relationship with suicidal behaviour, instead of being linked to an increased risk of several negative mental health outcomes. Distal factors are therefore thought to act indirectly, through developmental traits, which may be intermediate phenotypes, or endophenotypes, for suicidality 91, 92 .
Although it is unclear which specific genes contribute to the total genetic variance increasing predisposition to suicidal behaviour, family studies have consistently indicated that familial aggregation for suicidal behaviour is partly explained by transmission of impulsive aggressive traits. Familial clustering of suicidal behaviour is increased in families in which probands have higher levels of impulsive aggressive traits than in those in which probands have lower levels of such traits 19 . Moreover, compared with control individuals, relatives of suicide completers have elevated levels of impulsive aggressive traits and are themselves more likely to have histories of suicidal behaviour 22, 23 . In addition, impulsive aggressive traits show evidence of familial loading in families of suicide completers and mediate the relationship between family history and suicidal behaviour 23 . Thus, the transmission of behavioural traits (or endophenotypes 91 ) such as impulsive aggressive behaviours is probably explained by familial, and possibly genetic, susceptibility for suicidal behaviour.
In studies examining the link between endophenotypes and suicidality, anxiety, impulsivity and aggressive traits correlate with suicidal behaviour 23, 37, 93 . These findings have been supported by clinical and epidemiological studies on samples that are representative and nonrepresentative of the general population 94, 95 . Although they are more difficult to carry out than cross-sectional studies, longitudinal studies using multiple observation points offer stronger evidence of causal relationships and allow temporal relationships between different variables to be examined. A series of longitudinal and trajectory studies have investigated predictors of suicidal behaviour 37, 44, 45, [96] [97] [98] . Collectively, this work shows that high levels of childhood anxiety and disruptive behaviour (characterized by impulsivity, aggression, hyper activity and oppositional behaviour) are linked to suicidal behaviour in adulthood 93 . Supporting these findings, cross-sectional studies and two-point longitudinal studies have shown that stable anxiety and impulsive aggressive behaviour are associated with suicidality in adulthood [99] [100] [101] . ELA is likely to function through developmental dysregulation of behavioural and emotional traits. In animal studies, changes in the early-life environment correlate with stable behavioural phenotypes 102, 103 . For example, in non-human primates, social deprivation leads to sustained aggressive behaviour 102 . In humans, individuals with histories of ELA frequently show dysregulation of emotional and behavioural traits such as internalizing and externalizing disorders 104 , and the personality trait phenotypes of individuals with histories of ELA share characteristics with those that are seen among individuals with suicidal behaviour 37, 105 . However, this association is mitigated by other variables, such as sex and underlying disorders. Highanxiety trajectories fully mediate the relationship between ELA and suicide attempts among individuals with externalizing disorders, such as attention-deficit and hyperactivity and oppositional defiant and conduct disorders; among individuals without externalizing disorders, this mediation, although still marked, is only partial 90 . The relationships between these mechanisms may be used to explain the link between ELA and the development of high-anxiety trajectories (FIG. 1) . Similarly to high-anxiety trajectories, highly disruptive trajectories, which are characterized by high levels of impulsive aggressive traits, hyperactivity and oppositional behaviour, partially mediate the relationship between ELA and suicide attempts among females but not among males 90 . Approximately 40% of individuals who die by suicide have lifetime histories of alcohol dependence or abuse and around 25% have histories of illicit substance dependence or abuse 8 . Exact rates vary globally and between studies 6 , but there is a robust association between chronic substance use disorders and suicide. Impulsive traits strongly associate with substance use disorders and, although it is difficult to establish in human studies whether impulsivity is a cause or an effect of the chronic use of substances, animal experiments suggest that chronic substance use leads to increased impulsivity 33 . Interestingly, suicide cases that were associated with a high number of distal (predisposing) risk factors had particularly high levels of comorbidity with substance use disorders 106, 107 . Thus, chronic use of substances may further increase the levels of impulsive aggressive traits among individuals at risk of suicide. Consistent with this hypothesis, suicide completers with comorbid substance use disorders had higher levels of impulsive aggressive behavioural traits than those without such disorders 108 . The molecular factors underlying or correlating with mediators have not been well characterized to date but there are a few promising leads. Impulsive aggressive behaviours are associated with low levels of serotonin 109 , as discussed below, and suicidal behaviour is associated with low levels of cholesterol 24, [110] [111] [112] . Overall, studies exploring the link between cholesterol levels and suicidal behaviour have indicated that subjects with low serum cholesterol levels are at higher risk of suicidal behaviour, increased impulsive aggressive behaviour, violence and violent methods of suicide attempt (reviewed in REF. 24 ). The mechanisms underlying these relationships are unclear but brain cholesterol is essential for continued neural plasticity and it is tempting to speculate that predatory behaviours such as impulsive aggression are modulated to some degree by dietary needs, which correlate with serum lipid levels.
Proximal or precipitating factors
Suicidal crises are typically triggered by recent life events 113 and are strongly associated with the onset of episodes of psychopathology. Thus, approximately 90% of individuals who die by suicide meet criteria for a psychiatric disorder in their last 6 months of life, according to a large number of retrospective, proxy-based studies (known as psychological autopsies) 6 , epidemiological and registry-based studies 114 , and studies in clinical Figure 1 | Overview of the contributors to suicidal behaviour. Suicidal behaviour is regulated by several different factors that can be broadly categorized as distal (predisposing), developmental (mediating) or proximal (precipitating) factors. The model proposed in this Review takes into account the classic psychosocial and genetic risk factors for suicide and integrates newer findings on epigenetic changes associated with suicidality. Predisposing factors include family history of suicide and associated genetic predisposition, and early-life adversity and associated epigenetic changes. In both cases, predisposing factors lead to long-term effects on gene expression and regulation. Predisposing factors do not directly trigger suicidal events but are linked to increased suicide risk through the effects of mediating factors. Mediating factors -which may directly result from the gene changes that occur as a consequence of predisposing factors or which may be associated with other factors, such as chronic substance abuse -increase the risk of suicide by accentuating traits linked with suicidality. Specifically, family disposition and early-life events can shape behavioural and emotional traits such as impulsive aggressive behaviour and anxiety traits, increasing the risk of acting on suicidal ideation, which is a common feature of depressive psychopathology and hopelessness. Proximal risk factors, such as depressive psychopathology and acute substance abuse, can also be associated with genetic and epigenetic factors, and are often triggered by life events. at-risk populations 115 . Although only an average of 50% of individuals who die by suicide meet the criteria for MDD (a proportion that increases with age) at the time of death 6 , almost all individuals who are suicidal, regardless of their main psychiatric diagnosis, present some degree of suicidal ideation, hopelessness or other similar cognitive distortions that are characteristic of depressive states. When these cross-nosological depressive symptoms drastically alter the individual's problemsolving capacity and judgment, they may be interpreted as precipitants of suicidal crises. These depressive states are associated with molecular changes that are likely to underlie proximal risk factors for suicide and the most important of these are reviewed below.
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Serotonergic alterations. Decreased serotonergic neuro transmission mediates depressive states. Almost four decades ago, Asberg and colleagues 116 suggested that, among patients with depression, those with lower cerebro spinal fluid (CSF) levels of the serotonin metabolite 5-hydroxyindoleacetic acid (5HIAA) are more likely to show suicidal behaviour 116 . Subsequently, important post-mortem studies indicated altered serotonergic binding in the frontal cortex of suicide completers 117, 118 and, since then, researchers have extensively investigated serotonergic changes in suicide and related behaviours (reviewed in REF. 14) . A detailed discussion of this extensive body of work is beyond the scope of this Review. One of the most consistent findings suggests that responses to challenges with fenfluramine, which is a potent serotonergic agonist, is blunted among living subjects who attempted suicide 109 . In addition, post-mortem work using the brain cortex of suicide completers revealed decreased availability of the serotonin transporter 117 , and both post-mortem binding studies and in vivo studies using positron emission tomography (PET) have reported altered 5HT1A and 5HT2A receptor availability in suicidal brains, which suggests that insufficient serotonin in certain areas of the brain may be linked to suicidality 26, 27 . Two important questions remain in relation to the association between serotonin and suicide. The first question is to what extent are serotonergic changes in suicide explained by depressive psychopathology? Although there is some evidence suggesting that serotonin alterations may be specific to suicidal behaviour 119, 120 , these alterations partly overlap with those observed in the depressed brain. For example, the more pronounced sero tonergic changes observed in suicide might be a function of more intense hopelessness and suicidal ideation. This key point has not been adequately addressed, particularly in post-mortem brain studies, mainly because of the methodological challenges of assessing subjective and non-behavioural symptoms of depression by means of proxy-based interviews, which is the process whereby post-mortem brain studies obtain clinical information on the subjects they investigate. Another challenge is obtaining brain tissue from individuals who were affected by depression of equivalent severity to that presented by suicide completers, but who died from other causes. The second question is to what extent are serotonergic changes associated with suicide state markers of suicidality or depression, or trait markers of predisposition? There is evidence that lower serotonergic neurotransmission is also associated with behaviours that increase suicide risk, such as impulsive aggressive traits 121 , and that serotonergic genes have both shared and unique contributions to the risk for depression and suicidal behaviour 122 . However, it is also clear that changes in serotonin levels are associated with the onset of depressive and suicidal states in euthymic individuals who had previous depressive episodes 123 , and in individuals at risk for depression 124 . Thus, serotonergic changes underlie proximal depressive and suicide risk factors.
The polyamine stress response. Our group and others have studied changes in the polyamine stress response (PSR) system in the context of suicide. The PSR, like the HPA axis, is implicated in physiological responses to physical, emotional and hormonal stressors, including glucocorticoids
. The mRNA and protein levels of several components of the polyamine system are altered in cortical and subcortical brain regions of suicide completers [125] [126] [127] [128] , as well as in peripheral samples from suicide attempters 129, 130 and psychiatric patients 131 . In addition, non-human primate models of depression suggest that stress induces changes in gene expression that lead to altered brain polyamine levels 132 . Spermidine and spermine N1-acetyltransferase (SAT1), which is the rate-limiting enzyme in the catabolism of polyamines, is decreased in the cortex of suicide completers 125 and may even act as a peripheral biomarker of suicidality. Epigenetic regulation of some key polyaminergic genes, which involves different epigenetic processes in both biosynthetic and catabolic polyamine genes, has been reported in suicide cases [133] [134] [135] [136] . Although the evidence suggests differential epigenetic regulation of several poly aminergic genes in suicide, further studies are necessary to understand the external validity of these findings, their functional effect on the PSR and their relationship to peripheral markers.
Glutamatergic and GABAergic alterations. Several studies have been carried out over the past decade investigating the genome-wide transcriptomic changes that are associated with depression and suicide 137, 138 . These studies typically used mRNA microarrays to compare post-mortem brain tissue from individuals who were diagnosed with MDD and died by suicide with samples from individuals with good mental health who did not die by suicide. They reported dysregulation of genes involved in glutamatergic and GABAergic signalling in diverse cortical and subcortical regions. In particular, for GABAergic signalling, genes encoding GABA type A receptor subunits and their associated binding proteins were consistently found to be upregulated, notably in the prefrontal cortex, hippocampus and anterior cingulate 137, 138 . Among genes related to glutamatergic signalling, those encoding AMPA and NMDA glutamatergic receptor subunits were upregulated in the anterior cingulate and dorso lateral prefrontal cortex, whereas glutamate-ammonia ligase (GLUL; also known as glutamine synthetase), which is implicated in glutamate recycling, and the genes encoding the solute carriers solute carrier family 1 member 2 (SLC1A2) and SLC1A3 were downregulated in these cortical areas and in the amygdala 137, 138 . GLUL and the solute carriers are of particular interest, as these are primarily expressed in glial cells, which are altered in depression and suicide (see below). Although glutamatergic receptors have multiple functions and these expression differences may indicate global expression changes that may not be specific to the underlying psychopathological processes taking place in the suicidal brain, they are consistent with growing evidence of the efficacy of glutamatergic agents as rapid-acting antidepressants that are useful in the treatment of both depressed mood 139 and acute suicidal ideation 140, 141 .
Inflammatory factors. Much of the data produced over the past few decades supports a relationship between inflammation and depressive states 142 . Notably, such states have been linked to increased levels of pro-inflammatory cytokines, particularly tumour necrosis factor (TNF) and interleukin-6 (IL-6) 143, 146 . Furthermore, high levels of comorbidity have been observed between inflammatory autoimmune illnesses and depression, and a substantial proportion of patients undergoing therapy with cytokines, such as interferon-α (IFNα), have been found to develop depression [147] [148] [149] [150] . In contrast to the clear evidence indicating an association between changes in inflammatory markers and depressive states, there is only sparse evidence linking these markers to suicidal behaviour, but the data seem to support an association. There are several reports of an association between suicidal behaviourirrespective of depression status -and inflammatory cytokines (reviewed in REF. 151 ), with the most consistent results suggesting that patients with suicidal behaviour have an increase in levels of IL-6 and a decrease in levels of IL-2. Other inflammatory factors have been described to be altered in such individuals; for example, there have been reports of decreased levels of vascular endothelial growth factor (VEGF) 152 , increased levels of quinolinic acid 153 and increased levels of kynurenic acid in patients with MDD who have a history of attempted suicide 154, 155 . Although most studies investigating inflammatory markers in suicidal behaviour have used blood samples, some studies were carried out in CSF 153, 156 or in post-mortem brain tissue [157] [158] [159] [160] , and the results of these studies have led to the suggestion that suicide is associated with lowgrade inflammation in the brain. Glucocorticoids can blunt immune and inflammatory responses, but recent studies have shown that they can also stimulate immune responses in certain circumstances, such as during acute cellular damage or the death of brain tissue (reviewed Box 4 | The polyamine stress response system Polyamines are ubiquitous aliphatic molecules containing two or more amine (NH 2 ) groups. This group of molecules primarily comprises putrescine, spermidine, spermine and agmatine, the presence of which in mammalian brains was discovered relatively recently 223 . Polyamine synthesis is highly regulated, with several rate-limiting enzymes, such as ornithine decarboxylase (ODC), S-adenosylmethionine (SAM) decarboxylase (AMD1), and spermidine and spermine N1-acetyltransferase (SAT1). Their activities are tightly controlled by polyamine-mediated feedback loops. Other enzymes, such as spermidine synthase (SRM) and spermine synthase (SMS), may be induced in some conditions but otherwise have constant activity levels, whereas polyamine oxidase (PAO) activity is controlled by substrate availability 222 (see the figure) . Ornithine is produced through the metabolism of arginine in the urea cycle, which is itself controlled by substrate-limited enzymes.
Polyamines have a multitude of functions, including the regulation of gene transcription and post-transcriptional modifications, in addition to modulating the activities of several proteins 224 . Polyamines regulate the expression or release of several neurotransmitters, including catecholamines 225 , glutamate 226 , GABA 227 and nitric oxide 228 , and agmatine itself is thought to function as a neurotransmitter 229 . Polyamines also interact with several transmembrane channels and can thus influence the properties of excitable cells 226, 230 . In the mammalian brain, stressful stimuli such as physical, emotional and hormonal stressors, including glucocorticoids, elicit the polyamine stress response (PSR) 231 . Activation of the PSR results in elevated levels of putrescine and agmatine in both the brain and the peripheral tissues. The magnitude of the PSR is related to the intensity of the stressor and correlates with levels of behavioural and physiological responsiveness under stressful conditions 231 . The PSR can be pharmacologically manipulated 232, 233 , and there is strong evidence showing that elevated agmatine and putrescine levels in the brain are beneficial; numerous animal studies have shown that these compounds have both anxiolytic and antidepressant effects 234 , and polyamine depletion can produce altered emotional reactivity and anxiety-like behaviours 235 . Similarly, there are some encouraging pilot data in humans suggesting that agmatine has antidepressant properties 236 and, in agreement with these results, studies investigating the effects of antidepressants indicate a role for the polyamine system in the antidepressant response, particularly through allosteric binding of agmatine or putrescine to NMDA receptors 234 . AGMAT, agmatinase; dcSAM, decarboxylated S-adenosylmethionine; MTA, 5ʹ methylthioadenosine; SMOX, spermine oxidase. Nature Reviews | Neuroscience Glucocorticoid-mediated regulation of the immune system could lead to lasting effects of ELA on immunomodulation, as has been suggested by others 162 , and this is supported by the observation that victims of childhood maltreatment show heightened immune activation as adults 163 .
Glial and astrocytic dysfunction. Psychiatric phenotypes have traditionally been understood to result from dysfunction in brain neurons, and glia have been primarily investigated for their role in supporting neuronal function. As neuroscientists have gained increased insight into the diversity of functions that glial cells carry out in the brain, more interest has been paid to glial cells, and particularly to astrocytes, in psychopathology. Studies investigating animal models of depression have reported glial cell alterations, such as impaired glial function 164, 165 , and post-mortem brain studies have suggested that glial cell counts are decreased in cortical grey matter from patients with depression 166 , and that astrocytes are hypertrophied in cortical white matter from depressed individuals who died by suicide 167 . These results are in agreement with the findings from several mRNA expression studies using genome-wide microarrays in postmortem brain tissue from depressed individuals who committed suicide, which consistently showed alterations in the expression of several astrocytic genes 137, 168, 169 . Among the most pronounced findings, these studies have indicated a marked downregulation of the expression of connexin 30 (CX30) and CX43 -two genes encoding gap junction proteins that, in the brain, are almost exclusively expressed in astrocytes. Interestingly,
Cx30
-/-and Cx43 -/-mice show altered reactivity to novel environments and important changes in brain neurotransmitters, including serotonin 170, 171 . Other astrocytespecific genes have been reported to be differentially expressed in suicide completers; for example, expression of the gene encoding the truncated splice variant of TRKB (TRKB.T1), which lacks the catalytic activity of the full-length protein 172 , is reduced in the frontal cortex of suicide completers compared with control individuals 79 . This is consistent with results from work in mice indicating that mice overexpressing TRKB.T1 have an increased sensitivity to chronic social stress, which results in consistent social avoidance 173 . Neuroendocrine dysfunction in suicide. As discussed above, the HPA axis is dysregulated in individuals who have experienced ELA. In suicide attempters and completers, there is also evidence of HPA axis dysregulation, regardless of ELA history. Studies investigating suicide attempters have shown that HPA axis dysregulation correlates with the violence of the suicide attempt 174 . There is also evidence that HPA axis alterations may be more closely linked to suicidal behaviour than to individual psychopathologies, as the ability to suppress dexamethasone (which is a synthetic glucocorticoid used to measure the HPA axis response) predicts suicide completion 175 and suicidal behaviour in patients with MDD 176 . Post-mortem studies of suicide completers have revealed that such individuals have increased corticotropin-releasing hormone (CRH) activity in the paraventricular nucleus (PVN) [177] [178] [179] , increased CRH expression in the CSF 180 , fewer CRH-binding sites in the frontal cortex 181 , decreased glucocorticoid receptor expression in the hippocampus 54 and increased proopiomelanocortin (POMC) in the pituitary 182 , which indicates altered HPA axis function in the brains of suicide completers. Concordant with these findings is the observation that suicide completers have increased adrenal gland weight and adrenocortical hypertrophy 183, 184 , and relatives of suicide completers also show altered HPA axis responses in experimental evaluations of the stress response 185 .
Considerations for future directions
Suicide is a complex behaviour that results from the interaction of different factors. This Review examines evidence focusing on molecular changes associated with distal factors that increase the lifetime predisposition to suicide; the molecular and behavioural changes that are associated with factors mediating suicide risk; and, finally, those changes that are associated with depressive states that function as precipitants of a suicidal crisis (FIG. 1) . Although this Review discusses these factors as if suicidal behaviour were a single phenotype, this is not the case. There is only a partial overlap between suicide attempts and suicide completion, and there is clear clinical, phenomenological and probably aetiological heterogeneity in and between each of these phenotypes. Thus, aetiological models, such as the one discussed in this paper, are helpful as they provide theoretical relationships that can be tested, but they should not be taken at face value. In addition, many of the studies discussed in this Review focus on depression as a precursor to suicide but other psychiatric conditions, such as schizophrenia, bipolar disorder and personality disorders, are important contributors to suicidality, both in terms of suicidal ideation and suicidal behaviour 6, 101 . In this regard, the recently proposed diagnosis of suicidal behaviour dis order should be considered in future research, as suggested in DSM-5. This practice will help us to more effectively separate the neurobiological factors that are associated with suicidal behaviour from those that are related to psychopathology.
One avenue of investigation that may shed some light on the molecular basis of suicidality is the study of the molecular basis of treatment-emergent suicidal events and the mechanisms of action of pharmacological agents that affect suicidality. For example, recent advances in clarifying the mechanism of action of lithium suggest that it functions by modulating dopaminergic, glutamatergic and GABAergic pathways, as well as by upregulating neuroprotective factors, such as BDNF and apoptosis regulator BCL-2, and by downregulating apoptotic factors 186 . Lithium is effective at reducing the risk of suicide in patients with mood disorders, an effect that seems to be independent of its mood-stabilizing effect 187 , and it may also decrease aggression and impulsivity 188 . As such, further investigation of lithium activity in suicidal patients may identify new genes that are involved in suicidality. Similarly, studies investigating dynamic molecular changes associated with treatmentemergent suicidal events or with fast cessation of suicidal ideation, such as those seen following treatment with rapid-acting glutamatergic agents 140 , may indicate new molecular pathways of interest that will help us to understand suicide.
The studies discussed above have led to increased interest in the investigation of the epigenetic factors that are associated with both ELA and the molecular processes that mediate suicidality. However, before embarking on large sequencing-based studies, the field should consider several adjustments to the current approaches that could enhance the quality of the results generated. First, consortium-based initiatives, such as those seen in genetic variation studies of schizophrenia, should be promoted as they have recently produced encouraging results [189] [190] [191] . Second, alternative designs focusing on related phenotypes should be considered. For example, investigating simple Mendelian conditions such as Lesch-Nyhan disease 192 , for which the genetic architecture is reasonably well understood and phenotypes of interest such as self-injurious behaviours are manifested, should help us to identify gene pathways of interest. Third, a major focus of upcoming research initiatives should be to improve the comparability of the data. Standardizing the way that methodologies are reported (for example, by including the exact sequences of DNA regions investigated, detailed descriptions of probes or specific stimuli and details of the parameters that were controlled for) will improve comparability and help to avoid some of the drawbacks linked to genetic variability.
Other methodological aspects to consider for studies of suicide are the use of peripheral tissues to study epigenetic changes linked to suicidality and the use of tissue homogenates. Although epigenetic studies carried out on peripheral tissues are feasible and cost-effective, their scientific value has not been well characterized and we do not know the extent to which epigenetic modifications in peripheral tissues are representative of those in the CNS. Epigenetic regulation is, to a large degree, celland tissue-specific [193] [194] [195] , with greater epigenetic variability between different tissues of a single individual than between similar tissues of different individuals 61, [196] [197] [198] . Therefore, there is a need to clearly establish the relationship between peripheral epigenetic marks and CNS counterparts, a task that should become easier once reference epigenomic maps are generated from different brain regions and cellular fractions and compared with similar reference maps from peripheral tissues. In addition, studying single cell types can be facilitated through the use of laser-capture microdissection 199 or fluorescence-activated cell sorting 200 . Alternatively, computational methods facilitating the estimation of cell populations within tissue homogenates 201 could be used to refine results from studies using whole-tissue homogenates. Finally, epigenetic studies in suicide research to date have mainly focused on DNA methylation. However, other mechanisms of epigenetic regulation have been uncovered and should be further explored in the future
Such methodological improvements would allow us to confidently draw conclusions from studies on the epigenetic modifications linked to suicide and might accelerate the identification of useful biomarkers for increased risk of suicide. In the long-term, this would translate into better management of high-risk patients and improved health outcomes.
Box 5 | Rethinking epigenetic mechanisms in suicidal behaviour
Most epigenetic research investigating suicidal behaviours has so far focused on DNA methylation. As we gain insight into which different epigenetic marks are enriched in the brain, we should investigate the role of other epigenetic mechanisms that may be associated with suicidal behaviours, including the activity of intermediaries of cytosine methylation, histone modifications and the effects of non-coding RNAs.
Epigenetic modifications of cytosine residues lead to the formation of intermediate products of methylcytosine oxidation, such as hydroxymethylcytosine, formylcytosine and carbocytosine, all of which are enriched in brain tissue. These intermediaries are probably functional, and their potential contribution to the regulation of gene expression should be explored further. Cytosine methylation at sites other than CpG dinucleotides is also more prevalent in brain tissue than in other tissues. Most studies have so far focused on CpG methylation, and investigating the contribution of non-CpG methylation to the regulation of gene expression in brain tissue may be a promising avenue of research in suicide studies.
Histones are essential protein complexes that regulate the accessibility of DNA to transcriptional machinery by modulating the level of chromatin compaction. Post-translational modifications of the amino-terminal tails of histones change their effect on chromatin structure and activity. Specific genomic loci are linked to distinct histone modification profiles; for example, active promoters are associated with histone 3 lysine 4 (H3K4) dimethylation and trimethylation, and histone 3 lysine 27 (H3K27) acetylation and H3K4 monomethylation in enhancer regions, whereas repressed promoters are associated with H3K9 and H3K27 dimethylation and trimethylation. Specific contributions of histone modification to the emergence of suicide-related phenotypes have yet to be fully explored, but histone modification represents a ubiquitous mechanism for regulating gene transcription.
Another new aspect of epigenetic regulation of gene expression is the role of non-coding RNAs. A large proportion of the transcriptome is composed of regulatory RNAs that do not encode proteins and that instead regulate mRNA transcription, function and availability, and interact directly with DNA, regulatory proteins and enzymes. Among non-coding RNA species, long non-coding RNAs are of particular interest as they are highly expressed in the brain and are less evolutionarily conserved than other RNA species, and thus may associate with human brain processes that could be relevant to suicide research.
